BAXTER INTERNATIONAL INC acquires Fusion Medical Technologies, Inc.

BAXTER INTERNATIONAL INC acquired Fusion Medical Technologies, Inc., a transaction completed in May 2002, structured as Stock-for-stock merger at an exchange ratio of 0.1763 Baxter share per Fusion share (2,806,660 Baxter shares issued); non-cash transaction.

Fusion Medical Technologies, Inc. operates in BioScience, is based in Fremont, California, United States. Baxter acquired Fusion Medical Technologies, a Fremont, California company that developed and commercialized proprietary products used to control bleeding during surgery. Fusion's collagen- and gelatin-based hemostasis products (including FloSeal) complemented Baxter's fibrin-based biosurgery technologies, broadening its offerings to seal tissue, aid wound healing and manage active bleeding.

Added collagen- and gelatin-based hemostasis products complementing Baxter's fibrin-based biosurgery and tissue-regeneration portfolio.

Advisory firms were not disclosed for this transaction.

You're subscribed.

Thanks for signing up.